X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218231
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-20-2023-27421.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217517
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215837
https://recalls-rappels.canada.ca/en/alert-recall/pms-pazopanib-200-mg-tablet-presence-sorafenib
https://www.prnewswire.com/news-releases/xynomic-pharma-achieves-important-regulatory-milestones-in-china-and-eu-in-potentially-pivotal-kidney-cancer-and-lymphoma-trials-300813545.html
https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme
https://www.fiercebiotech.com/biotech/xynomic-preps-broad-push-for-hdac-cancer-drug-after-series-b
https://www.biospace.com/article/novartis-to-present-a-whopping-84-abstracts-at-asco-and-eha/
http://www.nasdaq.com/article/agrx-fails-to-secure-investor-confidence-itek-hit-hard-cbay-rises-on-kowa-deal-20170104-00025
http://www.prnewswire.com/news-releases/cytrx-announces-the-completion-of-enrollment-in-pivotal-global-phase-3-trial-ahead-of-schedule-300185476.html
http://www.fiercepharma.com/story/gsk-deals-done-now-novartis-has-deliver-cancer-growth-pledge/2015-03-02
Market Place
Share 
